Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 421 for “"Prodrugs"”.
-
Delivery of phosphonoformate prodrugs
… to improve transport properties are unsuitable prodrugs due to their rapid and complicated hydrolysis, involving competitive P-O and P-C bond cleavage. Diesters, though hydrolytically stable, are considered too polar to passively diffuse into the CNS. Hydrophilic drugs mimicking endogenous …
-
Prodrugs of antiviral phosphonates
… the transport properties of these molecules, prodrugs were synthesised and their stabilities and reconversion to the parent compound subsequently investigated by the techniques of 31P nuclear magnetic resonance spectroscopy and high performance liquid Chromatography. A series of 4-substituted …
-
PRODRUGS OF ENONES AS CANDIDATE ANTICANCER AGENTS
… Mannich bases. (ii) Oximes of Mannich bases as prodrugs were contemplated with a view to attain selective release of the ketones in the tumourous tissue. (iii) Benzoates as pro-prodrugs were proposed since oximes have a polar hydroxy group which may impede passage via membranes and also in the …
-
Pt(IV) anticancer prodrugs and liposomal encapsulation
… photoactivatable platinum based anticancer prodrugs. The use of liposomes as a method of drug encapsulation for a known platinum complex is also explored. Finally, the synthesis of a microbubble-liposome conjugated system and the sonoluminescence effect of microbubbles are assessed. Chapter …
-
Hypoxia-selective antitumor prodrugs and fluorescent probes
Hypoxia-selective antitumor prodrugs utilize the unique feature of most tumors -- hypoxia (low oxygen concentration), for therapeutic purpose and are widely studied in preclinical and clinical stages. Tirapazamine (TPZ, 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide) is a hypoxiaselective cytotoxin …
-
Characterization of photoactivatable Prodrugs of Kinase Inhibitors
… and characterization of novel photoactivatable prodrugs of several approved small molecule kinase inhibitors. Photoremovable protecting groups were therefore covalently bound to key pharmacophore moieties of active kinase inhibitors. The implementation of a protecting group distinctly diminished …
-
Evaluation of Antibiotic Release from Polymeric Prodrugs
… infections, we have designed synthetic polymeric prodrugs with cleavable linkers bearing an antibiotic drug. Previously, in vitro experiments using percent drug release to characterize the release kinetics of the prodrugs have been performed. However, acid and base hydrolysis have been used to …
-
Vascular regeneration using cells, biomaterials and prodrugs
Contains fulltext : 209726.pdf (Publisher’s version ) (Open Access)
-
Polymeric Prodrugs for Infectious Disease and Immune Therapies
… body of work, we explore the adoption of polymer prodrugs (“drugamers”) to facilitate the delivery and controlled release of small molecule drugs to multiple important therapeutic settings. First, we explain why drugamers synthesized by Reversible Addition Fragmentation-chain Transfer (RAFT) are …
-
Glycan polymeric prodrugs against pulmonary intracellular alveolar infections
… multivalent glycopolymer prodrug systems. Prodrugs are inactive forms of the drug, but when administered undergo hydrolysis to release the pharmacologically active drug. We hypothesized that engineering mannose glycopolymer prodrugs to target the macrophage mannose receptor on alveolar …
-
Pharmacokinetic studies of fluphenazine and four ester prodrugs
… parent compound FLU after administration of the prodrugs in oil based injections. It was determined that the sesame oil/buffer partition coefficients (PC) decreased as the homogenous series of the ester chain length was increased, the effect of the chain length of the prodrug on the release rate …
-
Photoactivable prodrugs based on oxygen and nitrogen heterocycles
… properties while retaining therapeutic activity. Prodrugs can be converted in vivo into the active drug, enzymatically or non-enzymatically, to exert a therapeutic effect. Also, there is a demand for spatial and temporal controlled drug delivery methods, which enable on demand release of …
-
Design of Safer Prodrugs Powered by Machine Learning
<p>Prodrugs are easily deployable chemical entities with beneficial pharmacokinetic properties that harness biotransformations to generate active pharmaceutical ingredients (APIs) in situ. However, the rational design of prodrugs is challenging as it requires careful crafting of release mechanisms …
-
Bioreductive prodrugs for the targeting of epigenetic enzymes
… by the observed side effects. In this project, prodrugs for a site-specific drug release were developed that are activated by the NADH-dependent bacterial nitroreductase NfsB (NTR) and subsequently release the LSD1 or HDAC inhibitor. The NTR, which is introduced into the cancer cell by …
-
Neue Prodrugs von Diamidinen zur Therapie protozoischer Erkrankungen
… dieser Arbeit wurden unterschiedliche doppelte Prodrugs von Diminazen und Pentamidin entwickelt, um deren chemischen und pharmakokinetischen Eigenschaften zu verbessern. Zur Erreichung dieses Ziels wurden mehrere Derivate der Diamidine synthetisiert, in vitro auf ihre Bioaktivierung hin …
-
Aktivierung eines photoresponsiven Kinaseinhibitor-Prodrugs durch Tscherenkow-Strahlung
… Charakterisierung dieses photoresponsiven Prodrugs wurde die Abspaltung der Schutzgruppe in Zusammenhang mit der von Radionukliden ausgesendeten Tscherenkow-Strahlung untersucht.
-
Development of Novel Polymeric Prodrugs for Antimicrobial Applications
… the development of polymeric and dendritic prodrugs that remain inactive under physiological conditions and are selectively activated at infection sites through external, biological, or chemical stimuli. The thesis begins with a systematic investigation into structure-activity relationships …
-
In vitro stability of cannabinergic prodrugs in plasma
… This issue can be addressed by creating prodrugs of these compounds with enhanced bioavailability. This study evaluates the in vitro half lives of monofunctional and bifunctional esteratic prodrug structures of two CB2-targeted cannabinergic drugs. These prodrug formulations have one or …
-
Self-Assembling Prodrugs: From Supramolecular Polymer to Supramolecular Medicine
… Specifically, I will use self-assembling prodrugs (SAPDs) as examples, which are an emerging class of supramolecular medicines that are able to associate into well-defined therapeutic supramolecular polymers in aqueous environments with tunable physicochemical and biological properties. In …
-
INVESTIGATION OF ASYMMETRIC PLATINUM (IV) COMPLEXES AS ANTICANCER PRODRUGS
… AND SEVERE SIDE-EFFECTS. PLATINUM(IV) ANTICANCER PRODRUGS CAN OVERCOME THESE LIMITATIONS BY RESISTING PREMATURE AQUATION AND BINDING TO ESSENTIAL PLASMA PROTEINS. CLASSICAL SYMMETRIC PLATINUM(IV) PRODRUG COMPLEXES ARE LIMITED IN THEIR SYNTHETIC UTILITY AS THEIR AXIAL LIGAND SITES FOR …
Page 1 of 22